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Recurrent tonsillitis has been the subject of frequent 
investigation. Misuse of antibiotic therapy in acute tonsillitis, 
changes to the tonsillar microflora, structural changes to 
the tonsillar crypts, and viral infections have been listed 
as predisposing or causal factors for recurrent tonsillitis. 
Epstein-Barr virus (EBV) infection usually occurs in early 
childhood and may persist in tonsillar lymphocytes, 
thus leading to the onset of recurrent tonsillitis. Little is 
known about the persistence and reactivation of EBV 
strains in immunocompetent patients. Methods such as in 
situ hybridization, polymerase chain reaction (PCR), and 
immunochemistry have been used to study the pathogenesis 
of the EBV. Aim: this study aims to characterize the association 
between EBV and recurrent tonsillitis by investigating the 
presence of EBV through PCR and immunohistochemistry, 
using viral protein LMP-1 as a target. Study design: this is 
a cross-sectional study with analysis of sample prevalence. 
Materials and method: twenty-four paraffin-embedded 
tonsil specimens from the Pathology Service were selected. 
The specimens were removed from children aged between 
2 and 12 years diagnosed with recurrent tonsillitis. Results: 
EBV genome was detected in 13 (54.1%) specimens, whereas 
viral protein LMP-1 was found in 9 (37.5%) specimens. 
Conclusion: children’s tonsils can be colonized by EBV 
and such colonies may be associated with the pathogenesis 
of recurrent tonsillitis.
Keywords: immunohistochemistry, epstein-barr virus infection, 
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INTRODUCTION
Waldeyer’s lymphatic ring is part of the first line 
of defense against pathogens; it is located at the entrance 
point of the airways and digestive tract. It consists of lym-
phoid tissue, which includes the palatine and pharyngeal 
tonsils. Many microorganisms may infect these tissues 
and cause tonsillitis; the most frequent are bacteria.1 The 
mechanism by which some children develop recurring 
tonsillitis is still unclear, as is the cause of exaggerated 
tonsillary enlargement. Many hypotheses have been raised, 
such as possible resistance of microorganisms to antibiotic 
therapy, and Streptococcus α interfering as an oropharyn-
geal protector against Streptococcus β to prevent recurring 
tonsillitis. Some studies have suggested that virus infections 
may be involved in recurring infections, including the 
Epstein-Barr virus (EBV) and herpes simplex viruses.2-4
The EBV was discovered in 1964 in a culture of 
Burkitt’s lymphoma cells; in 1968 studies revealed that it 
caused infectious mononucleosis.5 It is a herpesviridae of 
the subfamily gamaherpesvirinae, which infects most indi-
viduals before adult life. During the first infection, viruses 
are transmitted by saliva and invade the oropharyngeal epi-
thelial cells, which are destroyed; it then infects circulating 
B lymphocytes, within which the virus becomes latent.4 
The EBV genome consists of a linear 172 kilobase DNA 
molecule coding about 100 viral proteins; however, only 
10 genes are expressed in vitro in infected B lymphocytes 
(latency). These 10 genes consist of six nuclear proteins 
(EBNAs 1, 2, 3A, 3B, 3C and EBNA-LP), two membrane 
proteins (LMP-1 and LMP-2), and two small RNAs (EBER 
1 and EBER 2).6 The nuclear antigen protein 1 (EBNA-1) 
binds to the viral DNA so that the viral genome remains 
in infected cells as a circular episome; LMP-1 expression 
in immunocompromised individuals may induce B lym-
phocyte transformation and the onset of lymphoprolife-
rative conditions.6
In contrast with in vitro studies, the EBV replication 
site has not been established in vivo. Infectious mono-
nucleosis and oral hairy leukoplakia have been used as 
models for studying the replication mechanism of the 
virus.3 The EBV replication mode in healthy subjects is 
still unknown. The tonsils appear to be candidate sites 
for EBV replication.7,8 Babcock (1998) detected linear 
episomal forms of EBV DNA in tonsillary lymphocytes. 
These linear forms suggest that virus DNA is replicating 
in tonsillary lymphocytes in healthy subjects previously 
infected by the EBV. Until recently it was thought that 
the virus was capable of infecting only B lymphocytes 
and epithelial cells; there have, however, been reports of 
infected normal T lymphocytes.3
The EBV is associated not only with infectious 
mononucleosis but also with other benign diseases, such 
as oral hairy leukoplakia, and malignancies, such as 
Hodgkin’s lymphoma, non-Hodgkin’s B and T cell lympho-
mas, and nasopharyngeal, gastric and breast carcinomas. 
It is currently being associated with autoimmune diseases, 
such as lupus erythematosus and multiple sclerosis.5,9
Many molecular techniques are being used to de-
monstrate the presence of the EBV, such as the polyme-
rase chain reaction (PCR) and in situ hybridization (IHS). 
PCR makes it possible to detect minimal amount of viral 
DNA in tissues and smears. According to Peiper (1990), 
PCR amplification of specific EBV genome sequences is a 
rapid, sensitive and specific method for identifying viral 
DNA. Furthermore, this method makes it possible to stu-
dy biopsies that were paraffined and kept in files, which 
permits retrospective studies.
The purpose of this study was to investigate the 
association between the EBV and recurring tonsillitis by 
identifying the viral genome using PCR and the LMP-1 
proteins by using immunohistochemistry.
MATERIAL AND METHOD
A cross-sectional study was undertaken for 
analyzing the prevalence of EBV infection in tonsillec-
tomy specimens, in which the indication for surgery had 
been recurrence and significant volume increase. The 
Research Ethics Committee of the Faculdade de Medicina 
(Medical School) - CEP-CMM approved this study (number 
077/06). The slides of tonsillectomies with a diagnosis of 
hypertrophic chronic tonsillitis were selected among the 
tonsillectomies studied at the Pathology Unit from 1999 to 
2006. After excluding inadequate cases (insufficient mate-
rial, technical artifacts, inadequate fixation) 24 paraffined 
blocks with tonsils fixated in 10% buffered formaldehyde 
remained for study.
The nested PCR reaction using DNA extracted from 
three 5µm thickness tissue slices was used for identifying 
viral DNA. After sectioning each sample, the microtome 
was cleaned and the histological scalpels were changed. 
For DNA extraction the samples were deparaffinated in 
three xylene baths at 65ºC and hydrated with successive 
baths of 100%, 95% and 70% alcohol. After centrifugation, 
tissues were resuspended in 220µL of autoclaved milli-Q 
water and digested at 56ºC in the presence of 10% SDS 
(30µl) and K proteinase at 25mg% (6µL). K proteinase 
was added each day until the samples were completely 
digested. The suspension was extracted with phenol/chlo-
roform/isoamylic alcohol (25:24:1) to remove undigested 
proteins, and after DNA precipitation with sodium acetate 
(3M) (35µL) and absolute alcohol (1mL), the samples were 
centrifuged and resuspended with sterile milli-Q water 
(50µL).11 Extracted genomic DNA quality and estimated 
quantity was verified using 1.7% agarose gel electropho-
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resis containing ethidium bromide. The genomic DNA of 
all samples underwent β-globin gene PCR (constitutive cell 
gene) to check whether the samples contained amplifiable 
DNA. The nested PCR reaction to amplify the EBNA-1 gene 
was used for identifying the EBV DNA, generating a 279 
bp fragment in the first reaction and a 209 bp fragment 
in the second reaction.12 The first reaction mix, which 
identifies the herpex virus, contained 2.5µl of DNA from 
each extracted sample, 0.5µl of primers at 50µM (5’AAG-
GAG-GGT-GGT-TTG-GAA-AG 3’ and 5’AGA-CAA-TGG-
ACT-CCC-TTA-GC 3’), 2.5µl of a buffer solution (10mM 
TrisHCL pH8.3, 50mM of KCL), 0.75µl of MgCl at 2mM, 
2µl dNTP at 2mM, and 0.2µl of Taq polymerase Invitrogen 
(5U/µl), and enough milli-Q water to reach a 25 µl end 
volume. The DNA used as a positive control was extracted 
from the EBV virus infected B9507 cell line; the negative 
control was done with sterile milli-Q water. Amplification 
was done using the following program: 2 minutes at 94ºC, 
followed by 35 30-second cycles at 94ºC, 30 seconds at 
55ºC, and 30 seconds at 72ºC, followed by a 10 minute 
final extension at 72ºC. For the second reaction, specific 
primers for the EBV (5’ ATC-GTG-GTC-AAG-GAG-GTT-CC 
3’ and 5’ ACT-CAA-TGG-TGT-AAG-ACG-AC 3’) were used 
under the same conditions with the following program: 
45 seconds at 94ºC, followed by 35 20-second cycles at 
94ºC, 30 seconds at 55ºC, 30 seconds at 72ºC, followed by 
a 10 minute final extension at 72ºC. Identification of gene 
amplification was done using an ethidium bromide stained 
1.7% agarose gel, in which 7µl of each nested PCR product 
was separated by electrophoresis; a 100 bp molecular 
weight was used as the parameter (Fermentas).
To investigate the presence of the LMP-1 latency 
protein, paraffined blocks were microtomized and 5µm 
thickness sections were placed on pretreated slides with 
an adhesive (Silano®4%), after which deparaffining and 
washing with Tris-Buffered Saline was carried out. The 
slides were treated for antigen recovery during 30 minutes 
in a double boiler at 96ºC with a citrate buffer. The primary 
antibody was the monoclonal anti-LMP-1 (DAKO®) diluted 
at 1:400 according to the manufacturer’s instructions, and 
the kit LSAB (DAKO®) containing the biotinilated second 
antibody and the streptavidine and peroxidase conjugate. 
Revelation was done using a chromogenous solution (Kit 
DAB-DAKO®), and counterstaining was done with Harris’ 
hematoxyllin. Sections of lymphoma and inflammatory 
fibrous hyperplasia were used as positive and negative 
controls.
RESULTS
The sample used in this study originated from pe-
diatric patients aged from 2 to 12 years (mean 7.4 years, 
standard deviation 3.1 years), of which 15 (62.5%) were 
The genomic DNA visualized in agarose gel showed 
good quantity of DNA in extracted samples. Of 24 tonsils 
subjected to PCR, amplification of the β-globin gene was 
detected in 16 (66.7%) (Fig. 1). Of these, 10 (62.5%) ampli-
fied for the EBV genome (Table 1). EBV-DNA was detected 
in 13 (54.1%) of 24 tonsils (Fig. 2), of which 10 cases were 
from female patients (66.7% of 15 women) and 10 cases 
were from patients that comprised 58.8% of those aged 
from 6 to 12 years (Table 2). Investigation of the LMP-1 
latency protein in 24 tonsils revealed immune reactivity in 
few lymphocytes of 9 tonsils (37.5%) (Fig. 3).
Figure 1. Agarose gel (1,7%) electrophoresis showing amplification 
of the β-globin gene, (268bp) PM - Molecular weight 100bp, Samples 
1 - 12, C+ - DNA extracted from the line B9507, C- - Milli-Q water.
Table 1. Amplification of the β-globin gene and the EBV genome in 
tonsils.
Tonsils EBV + EBV -
βglobin+ 16 10(62,5%) 6(37,5%)
βglobin - 8 3(37,5%) 5(62,5%)
TOTAL 24 13(54%) 11(46%)
Figure 2. Agarose gel (1,7%) electrophoresis showing amplification 
of the EBV genome, (209bp) PM - Molecular weight 100bp, Samples 
1 - 17, C+ - DNA extracted from the line B9507, C- - Milli-Q water.
female and 9 (37.5%) were male. Tonsillectomy was indica-
ted due to tonsillary hypertrophy and adenoid vegetations 
in 17 cases, due to tonsillary hypertrophy and adenoid 
vegetations and recurring tonsillitis in 5 cases, and due to 
recurring tonsillitis in 2 cases.
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DISCUSSION
The Epstein-Barr virus causes infectious mononucle-
osis and oral hairy leukoplakia; it has also been associated 
with numerous malignancies including Hodgkin’s disease, 
B and T lymphomas, nasopharyngeal carcinomas, and 
gastric carcinomas in immunosuppressed patients. Little 
is known, however, about the pathogeny of the virus in 
Table 2. Distribution of 24 tonsils in the sample according to the sex and age of patients, the indication for tonsillectomy, the histopathological 
diagnosis and positive results for the EBV-DNA and the LMP-1 protein.
No Gender Age Tonsillectomy indication Histopathology diagnosis PCR LMP-1
1 M 10 PTAH Hypertrophic chronic tonsillitis - -
2 F 6 PTAH Hypertrophic chronic tonsillitis - -
3 F 9 PTAH & Repetition tonsillitis Hypertrophic chronic tonsillitis + +
4 M 4 PTAH Hypertrophic chronic tonsillitis - -
5 M 6 PTAH Hypertrophic chronic tonsillitis + +
6 F 7 PTAH & Repetition tonsillitis Hypertrophic chronic tonsillitis + +
7 M 6 Repetition tonsillitis Hypertrophic chronic tonsillitis - -
8 M 10 PTAH Hypertrophic chronic tonsillitis + +
9 F 9 PTAH Hypertrophic chronic tonsillitis + -
10 F 12 PTAH Hypertrophic chronic tonsillitis + -
11 M 6 PTAH & Repetition tonsillitis Hypertrophic chronic tonsillitis - -
12 F 12 PTAH & Repetition tonsillitis Hypertrophic chronic tonsillitis - -
13 M 5 PTAH Hypertrophic chronic tonsillitis - -
14 M 5 Repetition tonsillitis Hypertrophic chronic tonsillitis + -
15 F 12 PTAH Hypertrophic chronic tonsillitis - -
16 F 8 PTAH Hypertrophic chronic tonsillitis - -
17 F 6 PTAH Hypertrophic chronic tonsillitis + +
18 M 3 PTAH Hypertrophic chronic tonsillitis - -
19 F 4 PTAH & Repetition tonsillitis Hypertrophic chronic tonsillitis + -
20 F 12 PTAH Hypertrophic chronic tonsillitis + +
21 F 10 PTAH Hypertrophic chronic tonsillitis + +
22 F 2 PTAH Hypertrophic chronic tonsillitis + +
23 F 4 PTAH Hypertrophic chronic tonsillitis - -
24 F 10 PTAH Hypertrophic chronic tonsillitis + +
No = Case number   PTAH=pharyngeal tonsil and adenoid hypertrophy + positive - negative
Figure 3. Immunohistochemistry showing positive results for the LMP-1 
in cases A and B (1000X).
immunocompetent patients. Many researchers have sug-
gested that the tonsils are a possible replication site for 
this virus.2,3,8,13
Molecular techniques have been used often for diag-
nosing and monitoring patients with virus diseases. The 
EBV-DNA can be identified by in situ hybridization (ISH) 
and the polymerase chain reaction (PCR); some authors 
consider both equally sensitive for detecting the EBV.14 
Additionally, viral proteins found in latent and replicati-
ve infection may be identified by immunohistochemical 
techniques.2-4,13 The tonsils are considered the site of initial 
infection, and of viral persistence and replication. The EBV 
may infect the tonsils of children and become involved in 
recurring tonsillitis.2,15,16
In our study we selected the tonsils of children 
with a mean age of 7,4 years and a diagnosis of chronic 
and hypertrophic tonsillitis. We believe that the significant 
number of recurring tonsillary infections in childhood may 
be associated with the EBV; initial contact with this virus 
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often occurs around age 7 years. Sixteen of 24 tonsils 
showed positive amplification for β-globin, thus demons-
trating the presence of constitutional DNA, which was 
amplifiable, in the material that was extracted. In 10 of 
these 16, amplification of EBV was obtained, as in three 
tonsils that were negative for β-globin, suggesting that, 
although EBV-DNA was amplified in these three samples, 
we cannot state that the other five EBV-negative samples 
did not amplify by lack of the virus or low quantity or 
quality of DNA. It can be stated that the EBV infected 
54.1% of the tonsils in our sample; but mapping this 
infection, which would make it possible to identify the 
target cell population, faces technical limits. Niedobitek et 
al.17 used the ISH to define the pattern and distribution of 
EBV-positive lymphoblasts found mostly in extrafollicular 
areas. The prevalence of EBV infection in tonsillitis varies 
according to the detection method. Studies using the ISH 
for detecting EBER found a 26%,19 a 29%,2 and a 65%4 
association of the EBV with tonsillitis. Other studies using 
the PCR found a prevalence of up to 65% (11%,20 58%,15 
and 64%17). The PCR thus confirms its higher sensitivity for 
molecular detection, and suggests an association between 
the EBV and tonsillitis.
Ping-Ching Pai et al.’s15 results using nested PCR 
to investigate an association between the EBV and 57 
tonsillitis cases (58%) and 31 tonsils with malignancies 
(51%) suggest that the association is not restricted only to 
recurring tonsillitis.
Ikeda et al.3 (2000) used the ISH, the RT-PCR, and 
immunohistochemistry in 15 fragments of tonsils from 
patients with chronic tonsillitis. In a detailed study, these 
authors showed that tonsillary lymphocytes are not only a 
reservoir but also a replication environment for the EBV. 
Our results similarly found the LMP-1 (the EBV latency 
protein) in 37.5% of tonsils in our sample, showing that 
immunohistochemical methods may be an initial inves-
tigation method for latent EBV infection. Many question 
remain to be studies in the pathogeny of EBV infection; its 
association with the tonsils is particularly challenging.
CONCLUSION
Identification of a high (54.1%) prevalence of EBV-
DNA and identification of the LMP-1 (37.5%) in recurring 
tonsillitis in children suggest that the tonsils may be reser-
voir for the EBV, and that this virus may be involved in 
recurring infection. Many aspects of latent and replicative 
EBV infection remain unclear, and are possible points for 
future research.
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